# A Study to Evaluate the Effects of Single and Multiple Doses of Hemay005 Tablets in Health Caucasian Adult Volunteers

> **NCT05941247** · PHASE1 · COMPLETED · sponsor: **Ganzhou Hemay Pharmaceutical Co., Ltd** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Hemay005 60 mg

## Key facts

- **NCT ID:** NCT05941247
- **Lead sponsor:** Ganzhou Hemay Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-07-17
- **Primary completion:** 2023-08-08
- **Final completion:** 2023-08-20
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-03-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05941247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05941247, "A Study to Evaluate the Effects of Single and Multiple Doses of Hemay005 Tablets in Health Caucasian Adult Volunteers". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05941247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*